Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. - Wikidata - awgldk - TriplyDB

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

http://www.wikidata.org/entity/Q36225916

about

Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach Quantitative airway assessment on computed tomography in patients with alpha1-antitrypsin deficiency.α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.Longer telomere length in COPD patients with α1-antitrypsin deficiency independent of lung function Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study.Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies.Ecogenomics of respiratory diseases of public health significance Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency.IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.Enhancing Autophagy with Drugs or Lung-directed Gene Therapy Reverses the Pathological Effects of Respiratory Epithelial Cell Proteinopathy.Gene-environment interactions in chronic obstructive pulmonary disease.Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.Asthma and COPD in alpha-1 antitrypsin deficiency. Evidence for the Dutch hypothesis.Airway disease in alpha-1 antitrypsin deficiency.Recent advances in α-1-antitrypsin deficiency-related lung disease.Risk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Telomerase and the Genetics of Emphysema Susceptibility. Implications for Pathogenesis Paradigms and Patient Care.Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.Impact of aluminum exposure on lung.Alpha 1-antitrypsin ameliorates ventilator-induced lung injury in rats by inhibiting inflammatory responses and apoptosis.α1-Antitrypsin deficiency.Detecting Familial Aggregation.Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement Sequencing Alpha-1 MZ Individuals Shows Frequent Biallelic Mutations

P2860

Q22306038-285D91C4-FD82-492D-807D-1E931DEFA86B Q28392320-269158F3-1CFF-46DC-A1CE-0A949064BA89 Q34154068-53683860-CD50-4235-8DB4-EE7F9F3F7482 Q34428735-19E60EE0-DC14-4D13-9048-AB93BAE776B8 Q35156969-7BD2B538-DB26-4C90-9F9B-D8B65E4F6752 Q35782675-1F815E51-AA73-40D6-94C4-ADD7D277EAD7 Q35837259-5E7D02D0-F47C-459E-B86C-9659A3110352 Q35854156-D406EAFB-64D2-4C6C-B1A5-D8596668F74D Q36108823-FF840058-456E-4819-9494-9F41D83BD01E Q36149225-C31D18AB-1436-4D94-8840-A49C49354DAF Q36330718-9E8DA28B-FC8D-471C-A7E1-E6E3AD1C9AD5 Q36444154-82992F13-6292-4B26-9F16-B6E5F5312B2D Q37070366-1E41CF94-FFCD-4997-B541-EBA840230C7A Q37362591-1E8A4AED-CA83-4FC4-8113-A57D7138F3A2 Q37395410-EB7CBE77-174A-47DA-A4EC-0369C7116D10 Q37474870-CA90B8C6-B3FB-44A3-A97C-3F1E6A8B3DD7 Q37790365-6992B9C3-4C6C-4F4F-9155-9B36A3ED0BE0 Q38092905-4C939F07-49A0-44B6-B5B6-1B29463B1258 Q38111790-7A346F14-E9CB-4D81-8D07-F5AD5B1EE40D Q38827548-2B98A9A7-5610-4898-884E-F2F30D87B86E Q38933451-19BFD8A1-9AD2-4982-A6EF-29C9D62D2517 Q38937849-E5D4B85B-16FD-440D-B5AE-32BE37407253 Q38988633-DC50CE6A-36A2-4240-99B4-F3B384F00043 Q39049242-EA92FE9B-88EE-4C72-B7FB-3A64B8B7F647 Q41138327-1906A577-1FF4-4B0F-AA74-07B74EC6B478 Q46606639-9473D471-53DB-4558-89EB-0467161ABA64 Q47448909-42C0692A-B6B4-49B3-A240-93FB4C5B1FD6 Q51481224-3776C1F0-9BBE-4099-8B90-73E339B03EC2 Q54632295-F48B3AEF-D2BB-43F7-9EE2-8944C61861C0 Q58580727-2BE36B60-AF0A-4E11-A4AE-302036F163BA Q58762724-41580087-08BD-42C4-BDB8-2244F9BE33BA

P2860

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

http://www.wikidata.org/entity/Q36225916

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

@ast

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

@en

type

label

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

@ast

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

@en

prefLabel

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

@ast

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

@en

P1433

Q36225916-B4500734-DF80-436B-8F36-6455E45AE5C1

P1476

Q36225916-C88F9471-E44A-4CA1-B156-17C7881ADEBD

P2093

Q36225916-2FB9BD43-DBC5-4F27-99B8-39A817B4D8D8

Q36225916-45B072C5-D512-4165-A071-E25B45E9B098

Q36225916-733704B9-8DCA-4356-BF1A-4531B450FDAC

Q36225916-80EA4BD1-5321-42AC-970C-FE33CB5C55CD

Q36225916-8D3C1D4D-8CB4-4571-90CF-958E5A6290D1

Q36225916-966E8A10-AE16-4DC4-B58A-A5DECA49CF12

Q36225916-9D9E3988-5D60-4C08-966C-C43CA5A4BC3E

Q36225916-9FA0BF02-1713-4388-A61A-52868C7D5ED5

Q36225916-AA90C806-664B-402F-82CE-877A1853B29B

Q36225916-BFC125B3-1A88-4B0F-9362-9B56ED950AD0

P2860

Q36225916-13153468-CBB4-4DF2-B421-B9D706967921

Q36225916-21A951E5-5DFE-4AEC-A93E-FB2AA6F3C5A5

Q36225916-21C5A003-D30D-4653-8A7A-8C6D19B5C229

Q36225916-23D56CC7-7DD7-4895-9604-B42CE7F9E5F2

Q36225916-30229BB9-2B05-4CD7-B3A0-90B08F1D4B0D

Q36225916-3A70DCE3-14AF-4EBB-98E0-0E43D03B85BA

Q36225916-4183EC00-A4E3-4D24-9121-A5A4ACAC469C

Q36225916-5CEB1258-C9D3-468D-9263-CF8669AFB666

Q36225916-6A93DAF8-7C5D-4062-AFC6-8FB3E010931E

Q36225916-8025F31F-5EBA-4D0C-997D-66C3ADF98F14

P304

Q36225916-24BA9E8E-EC61-470D-A417-826570D96AAC

P31

Q36225916-8C89116E-C298-4CCB-8606-7766769872C9

P356

Q36225916-919781C1-486F-4F00-B935-26B5EAA04049

P407

Q36225916-24F60C6F-3FBE-4FD9-8649-FBDD42745DC2

P433

Q36225916-3ED5FDB7-8170-4262-A28B-BB3A54A31D59

P478

Q36225916-992B587B-DEAD-4873-80AF-8C0A5AEB3B6A

P577

Q36225916-0C8605DC-5082-4C03-B290-2159C671AD85

P5875

Q36225916-EC4FF980-EC1F-47DF-825E-58F918902C86

P698

Q36225916-6835073A-A150-4D36-83C8-E4ECEE59D477

P932

Q36225916-CD150DF8-A5B8-4DF1-BB81-066F56BD7E09

P356

THX.2006.075846

P1433

P1476

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

@en

P2093

Alan F Barker

http://www.w3.org/2001/XMLSchema#string

Charlie Strange

http://www.w3.org/2001/XMLSchema#string

Dawn L Demeo

http://www.w3.org/2001/XMLSchema#string

Edward Eden

http://www.w3.org/2001/XMLSchema#string

Edward J Campbell

http://www.w3.org/2001/XMLSchema#string

Edwin K Silverman

http://www.w3.org/2001/XMLSchema#string

Esteban Burchard

http://www.w3.org/2001/XMLSchema#string

Gerard M Turino

http://www.w3.org/2001/XMLSchema#string

James K Stoller

http://www.w3.org/2001/XMLSchema#string

James M Stocks

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

Standardization of Spirometry, 1994 Update. American Thoracic Society

Epidemiology Standardization Project (American Thoracic Society)

The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. 1963.

Reference spirometric values using techniques and equipment that meet ATS recommendations.

Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ)

Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).

Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening.

alpha1-Antitrypsin deficiency in nonsmokers.

Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.

P304

806-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2006.075846

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51374718

http://www.w3.org/2001/XMLSchema#string

P698

17389752

http://www.w3.org/2001/XMLSchema#string

P932

2117297

http://www.w3.org/2001/XMLSchema#string